Health & Tech
Medical advances and useful technology already helping people, or shown in human trials.
Health & TechTen people with advanced retinitis pigmentosa received an experimental optogenetic injection plus special goggles. Some sensed light better. Normal vision did not return.
Verified · University of Pittsburgh
Health & TechIn a 654-person maintenance trial, median progression-free survival was 24.9 months with tucatinib and 16.3 months with placebo. Overall survival is not known yet.
Verified · U.S. Food and Drug Administration
Health & TechIn a 282-person trial, the cancer took longer to worsen than with a common chemoimmunotherapy. Survival is not proven, and the approval excludes a 17p deletion.
Verified · U.S. Food and Drug Administration
Health & TechIn a study of 62 children, the Autus valve met the FDA's six-month bar. Only two have been expanded so far, and longer follow-up is still underway.
Verified · U.S. Food and Drug Administration